Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Paris - Delayed Quote EUR

Nanobiotix S.A. (NANO.PA)

Compare
3.0000
-0.0050
(-0.17%)
At close: April 17 at 5:35:21 PM GMT+2
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for NANO.PA

Recent News: NANO.PA

View More
Voting Rights and Shares Capital of the Company

Voting Rights and Shares Capital of the Company
GlobeNewswire 4 days ago
Nanobiotix SA (NBTX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges

Nanobiotix SA (NBTX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
GuruFocus.com 14 days ago
NANOBIOTIX Provides Business Update and Reports Full Year 2024 Financial Results

NANOBIOTIX Provides Business Update and Reports Full Year 2024 Financial Results
GlobeNewswire 16 days ago
NANOBIOTIX to Announce Fourth Quarter and Full Year 2024 Operational and Financial Update on April 2, 2025

NANOBIOTIX to Announce Fourth Quarter and Full Year 2024 Operational and Financial Update on April 2, 2025
GlobeNewswire 18 days ago
Nanobiotix Announces First Data From the Completed Dose Escalation Part of a Phase 1 Study Evaluating NBTXR3 (JNJ-1900) as a 2L+ Therapy for Patients With Locally Advanced NSCLC

Nanobiotix Announces First Data From the Completed Dose Escalation Part of a Phase 1 Study Evaluating NBTXR3 (JNJ-1900) as a 2L+ Therapy for Patients With Locally Advanced NSCLC
GlobeNewswire 22 days ago
NANOBIOTIX Announces Presentation of Data From Two Phase 1 Studies Evaluating JNJ-1900 (NBTXR3) at the European Lung Cancer Conference

NANOBIOTIX Announces Presentation of Data From Two Phase 1 Studies Evaluating JNJ-1900 (NBTXR3) at the European Lung Cancer Conference
GlobeNewswire 29 days ago
NANOBIOTIX Strengthens Financial Position Through Amendment of Global Licensing Agreement for JNJ-1900 (NBTXR3) and Extends Cash Visibility to Mid-2026

NANOBIOTIX Strengthens Financial Position Through Amendment of Global Licensing Agreement for JNJ-1900 (NBTXR3) and Extends Cash Visibility to Mid-2026
GlobeNewswire last month
Is Nanobiotix (NBTX) the Best Nanotech Penny Stock to Invest In?

Is Nanobiotix (NBTX) the Best Nanotech Penny Stock to Invest In?
Insider Monkey 2 months ago
Nanobiotix to Participate in Multiple Investor Conferences in February and March 2025

Nanobiotix to Participate in Multiple Investor Conferences in February and March 2025
GlobeNewswire 2 months ago
Nanobiotix Stock Gains as Dosing Begins in Mid-Stage NSCLC Study

Nanobiotix Stock Gains as Dosing Begins in Mid-Stage NSCLC Study
Zacks 2 months ago
NANOBIOTIX Announces First Patient Dosed in a New Randomized Phase 2 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer

NANOBIOTIX Announces First Patient Dosed in a New Randomized Phase 2 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer
GlobeNewswire 2 months ago
View More

Related Tickers

XBRANE.ST Xbrane Biopharma AB (publ)
0.1946
-4.04%
 
HQ1.MU Oruka Therapeutics Inc. R
7.50
+2.04%
 
05Y.MU Vivoryon Therapeutics NV
1.7140
0.00%
 
MVR0.BE Medivir AB
0.1372
-2.42%
 
BT3.BE Lineage Cell Therapeutics Inc
0.3600
-1.10%
 
2X1.SG Abivax SA
5.25
+1.35%
 
PROT Proteonomix, Inc.
0.0000
0.00%
 
DBV.F DBV Technologies S.A.
1.2520
+1.79%
 
HTD.MU Corcept Therapeutics Inc
57.90
-3.60%
 
ICY.HA Incyte Corp
51.16
-0.31%